Effects of a lipid emulsion containing fish oil on polyunsaturated fatty acid profiles, growth and morbidities in extremely premature infants: A randomized controlled trial
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background & aims The purpose of the study was to compare the effects of the parenteral emulsion SMOFlipid ® , with 15% fish oil, with Clinoleic ® on retinopathy of prematurity (ROP) and other morbidities and growth, and to compare their impact on longitudinal serum levels of fatty acids. Retinopathy of prematurity, other morbidity and growth were correlated with each parenteral lipid supplement. Methods Ninety infants born at gestational age <28 weeks were randomized to treatment with SMOFlipid ® or Clinoleic ® . Two thirds (66%) of the infants received parenteral nutrition for up to 14 days birth (median 8, range 2–14 days), and additional 25% of the infants received for up to 28 days after birth (median 21, range 15–28 days). Cord blood samples and then venous blood samples were obtained at ages 1, 7, 14, and 28 days and at postmenstrual age (PMA) 32, 36, and 40 weeks. Breastmilk was collected at postnatal day 7, and at PMA 32 and 40 weeks. Serum phospholipid and breastmilk total fatty acids were analyzed by gas chromatography–mass spectrometry. Treatment groups were compared with regard to ROP, bronchopulmonary dysplasia, necrotizing enterocolitis, patent ductus arteriosus sepsis and growth between birth and 36 weeks. Results Infants on SMOFlipid ® had higher fractions of omega-3 LCPUFA eicosapentaenoic acid (EPA) and slightly higher omega-3 LCPUFA docosahexaenoic acid (DHA) fraction and a decreased arachidonic acid (AA) to DHA ratio from one week after birth up to 32 postmenstrual weeks compared to infants on Clinoleic ® . Treatment groups did not differ in morbidities or growth. Conclusion Supplementation with SMOFlipid ® containing 15% fish oil during parenteral nutrition increased EPA substantially, DHA marginally, reduced AA and decreased AA to DHA ratio. It did not reduce morbidity or affect growth. Since extremely preterm infants accumulate a large deficit of DHA and AA, studies on more prolonged or different levels of DHA and AA supplementation are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators
Serhan, C. N., Chiang, N., & Van Dyke, T. E. (2008) · Nature Reviews Immunology · doi:10.1038/nri2294 · Cited by 2,932
Towards sustainable sources for omega-3 fatty acids production
Adarme-Vega, T. C., Thomas-Hall, S. R., & Schenk, P. M. (2014) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2013.08.003 · Cited by 250
Fu, Z., Lofqvist, C. A., Shao, Z., Sun, Y., Joyal, J.-S., Hurst, C. G., Cui, R. Z., Evans, L. P., Tian, K., SanGiovanni, J. P., et al. (2015) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.114.099291 · Cited by 76
Self-citation
Cited by
Nutrients and Microbiota in Lung Diseases of Prematurity: The Placenta-Gut-Lung Triangle
Piersigilli, F., Van Grambezen, B., Hocq, C., & Danhaive, O. (2020) · Nutrients · doi:10.3390/nu12020469 · Cited by 64
Biological and Clinical Aspects of an Olive Oil-Based Lipid Emulsion—A Review
Cai, W., Calder, P. C., Cury-Boaventura, M. F., De Waele, E., Jakubowski, J., & Zaloga, G. (2018) · Nutrients · doi:10.3390/nu10060776 · Cited by 48
Suzumura, A., Terao, R., & Kaneko, H. (2020) · Antioxidants · doi:10.3390/antiox9100920 · Cited by 44
“By contrast, intravenous administration of fish-oil-based lipid emulsion (SmofLipid®, Fresenius Kabi), a blend of plant- and animal-based lipid emulsions with a higher n-6/n-3 fatty acids ratio than in the diet, resulted in less ROP but did not alter the requirement for laser treatment or the ROP frequency [119,120].”
BackgroundBoeck, M., Yagi, H., Chen, C. T., Zeng, Y., Lee, D., Nian, S., Kasai, T., Lee, J., Hirst, V., Wang, C., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.03.004 · Cited by 4
Metadata
- Authors
- Najm, S., Löfqvist, C., Hellgren, G., Engström, E., Lundgren, P., Hård, A.-L., Lapillonne, A., Sävman, K., Nilsson, A. K., Andersson, M. X., Smith, L. E. H., & Hellström, A.
- Venue
- Clinical Nutrition ESPEN
- Publisher
- Elsevier BV
- Published
- 2017-08
- Volume
- 20
- Pages
- 17-23
- ISSN
- 2405-4577 (ISSN-L)
- OpenAlex
- W2610403609
- Cited by
- 139
- References
- 3
- FWCI
- 9.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.